1. Engineered bacteria direct the tumor-specificity of CAR-T cells to enable antigen-agonistic tumor targeting Vincent, Rosa Louise 2024 Theses ImmunologyOncologyBacterial genetic engineeringTumors--TreatmentTumors--Genetic aspectsEscherichia coli--ResearchT cellsLeukemia--Treatment
2. A pathogenic function of regulatory T cells in chronic liver disease and Chemokines expressed by engineered bacteria recruit and orchestrate anti-tumor immunity Savage, Thomas M. 2023 Theses ImmunologyT cellsLiver--DiseasesCytokines--ImmunologyCytokines--Therapeutic useBacterial genetic engineering